Request Demo
Last update 31 May 2025
VEGF (NIH)
Last update 31 May 2025
Overview
Basic Info
Drug Type Biological products |
Synonyms VEGF (NIH) |
Target |
Action agonists |
Mechanism VEGFR agonists(Vascular endothelial growth factor receptor agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingClinical |
First Approval Date- |
Regulation- |
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Peripheral Vascular Diseases | Clinical | United States | - |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Not Applicable | VEGF | - | VEGF (Control ARPE-19 cells) | quthrpjaxr(txwsgvrhkq) = mkuxopakew ehnjizegqx (lmkuoqmexy ) View more | - | 01 May 2022 | |
Not Applicable | 23 | Patients treated with sirolimus | kjwxunjang(uejzxpanyh) = hladknfgcx twaqrhfpqj (aslxfutold ) | - | 28 Sep 2019 | ||
Not Applicable | Retinal Diseases vascular endothelial growth factor (VEGF) | - | VEGF (PDR) | jafyzpwbxp(tgqpwtdcxq) = ywdcmjeciu blwclzttmt (jbjwpbzcji ) | - | 01 Jul 2019 | |
VEGF (CRVO) | jafyzpwbxp(tgqpwtdcxq) = mgbhzjjups blwclzttmt (jbjwpbzcji ) | ||||||
Not Applicable | - | - | VEGF (Untreated cells) | mqpfyafhcm(dbyumrunsz) = pssjlolgxx scclwabsfo (tgfwgsdwhb ) | - | 01 Apr 2009 | |
Not Applicable | Retinal Diseases VEGF | - | VEGF (Ischemic preconditioning) | axgwqmcyje(demixwalju) = wyokmjfzaz lciuiucetx (hiscioxbtz ) | - | 01 May 2004 | |
Not Applicable | Retinal Vein Occlusion vascular endothelial growth factor (VEGF) | 7 | VEGF (Branch Retinal Vein Occlusion (BRVO)) | wvsgvdjiui(eovnwhmhdv) = srbkzsdkdn fkuzjelxas (kbheorslfv, 0 - 552) View more | - | 01 May 2004 | |
VEGF (Hemi-Retinal Vein Occlusion (HRVO)) | wcaqqkfcfu(thoomrzmfq) = xrnxsbijgs nnsbegvzro (grpgmosloz ) |
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free